Nikolas Weissmueller·Sep 8Mind Your Metrics: Beyond FSA and LSA for Site ActivationBetter questions lead to better answers, and better metrics enable better questions. Clinical operations is replete with metrics: counts…
Nikolas Weissmueller·Apr 7, 2025Why Accelerating Clinical Trial Enrollment Has Diminishing ReturnsIn pharmaceutical development, delays can wipe out billions of dollars. Clinical programs routinely aim to accelerate trial timelines by…
Nikolas Weissmueller·Sep 12, 2024Detecting Data Bias with Kullback-Leibler DivergenceData bias can lead to incorrect conclusions and flawed decisions. The Kullback-Leibler (KL) divergence can help identify such biases in…A response icon1A response icon1
Nikolas Weissmueller·Sep 8, 2024Faster Normal ProbabilitiesFaster but less accurate: A Bounded Integral for the Normal Distribution
Nikolas Weissmueller·May 19, 2024Elevating Scoring SystemsA Probabilistic Approach to Risk Assessment
Nikolas Weissmueller·Apr 16, 2024Simplicity from complexityA Non-Proportional Hazards Survival Analysis Example
Nikolas Weissmueller·Mar 31, 2024You need a Quant TeamAs a data-driven organization, if you invest in data, you should also invest in methods and suitable governance for both.
Nikolas Weissmueller·Mar 28, 2024The Schoenfeld ShortcutRough and Ready Survival Analysis Study Sizing
Nikolas Weissmueller·Mar 20, 2024Hard Truths About P-ValuesSignificance is not importance. Insignificance is not unimportance.A response icon1A response icon1
Nikolas Weissmueller·Mar 18, 2024Navigating Uncertainty: Market Planning with Sequential Decision AnalysisImagine you’re the captain of a ship, navigating through treacherous waters filled with hidden reefs and unpredictable storms. Every…